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Feline Hypertrophic Cardiomyopathy, the Consequence of Cardiomyocyte Initiated and 
Macrophage Driven Remodeling Processes? 
 
Hypertrophic cardiomyopathy is the most commonly diagnosed cardiac disease in cats. 
Its complex pathophysiology is still not clear, but myocardial remodelling is a key 
process, and cardiomyocyte disarray, interstitial fibrosis, leukocyte infiltration and 
vascular dysplasia are described histopathologic features.  
The present systematic pathological study aimed to shed more light on the 
pathogenesis of HCM.   
Hearts from each 18 HCM and control cases were examined, using light and 
transmission electron microscopy, immunohistochemistry and morphometric 
approaches to identify and quantify the morphological changes. Quantitative reverse 
transcriptase PCR served to gain mechanistic data on remodelling processes. In HCM, 
the left and right ventricular free wall and septal myocardium exhibited a significantly 
reduced overall cellularity, accompanied by a significant increase in interstitial Iba1-
positive cells with macrophage morphology. In addition, the myocardium of almost half 
of the diseased hearts exhibited areas where cardiomyocytes were replaced by cell rich 
fibrous tissue with abundant small and medium sized vessels. HCM hearts also showed 
significantly higher transcription levels for several inflammatory and profibrotic 
mediators.  
The results suggest that HCM is the consequence of cardiac remodeling processes that 
are the result of cardiomyocyte damage and to which macrophages contribute by 
maintaining an inflammatory and profibrotic environment.  
 
Keywords: cat, heart, hypertrophic cardiomyopathy, morphometry, myocardium, 
histopathology 
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Feline Hypertrophe Kardiomyopathie, die Konsequenz eines von 
Kardiomyozyten initiierten und Makrophagen gesteuerten 
Umbauprozesses?  
 
Hypertrophe Kardiomyopathie (HCM) ist die häufigste diagnostizierte 
Herzerkrankung bei Katzen. Ihre komplexe Pathophysiologie ist noch 
unklar,  
aber myokardialer Umbau ist ein Hauptprozess und kardiomyoztärer 
‘Disarray’, interstitielle Fibrose, leukozytäre Infiltrate und vaskuläre 
Dysplasien sind beschriebene histologische Merkmale.  
Die vorliegende systematische pathologische Studie diente dazu, mehr 
Klarheit zur Pathogenese der HCM zu erlangen. Herzen von 18 HCM-
Fällen und Kontrollkatzen wurden mittels Lichtmikroskopie einschliesslich 
Immunhistochemie und morphometrischen Ansätzen sowie 
Transmissionselektronenmikroskopie  untersucht, um die morphologischen 
Veränderungen zu identifizieren und zu quantifiziere. Mittels RT-PCR 
wurden Daten zu Umbaumechanismen gewonnen. Bei HCM wies das 
Myokard der linken und rechten Ventrikelwand und des Septums eine 
signifikant reduzierte Zellzahl, sowie signifikant mehr interstitielle Iba-1-
positiven Zellen (Makrophagen) auf. Bei nahezu der Hälfte der Fälle 
fanden sich Herde, in denen das Myokardium durch zellreiches 
fibrovaskuläres Gewebe ersetzt war. Ausserdem war die HCM mit einer 
signifikant erhöhten Transkription einiger Entzündungs- und profibrotischer 
Mediatoren verbunden.  
Die Ergebnisse weisen darauf hin, dass die feline HCM Folge kardialer 
Umbauprozesse ist, die sich infolge Kardiomyozytenschädigung und durch 
Makrophagen aufrechterhaltene entzündliche und profibrotische Prozesse 
entwickelt.  
 
 
Stichwörter: Katze, Herz, Hypertrophe Kardiomyopathie, Morphometrie, 
Myokardium, Histopathologie 
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Abstract  
Hypertrophic cardiomyopathy (HCM) is the most commonly diagnosed cardiac 
disease in cats. The complex pathophysiology of HCM is still far from clear, 
but myocardial remodeling is a key process, and cardiomyocyte disarray, 
interstitial fibrosis, leukocyte infiltration and vascular dysplasia are described 
histopathologic features. The present study systematically investigated the 
pathological processes in HCM, with the aim to shed more light on its 
pathogenesis. Hearts from 18 HCM cases and 18 cats without cardiac 
disease (controls) were examined, using light and transmission electron 
microscopy, immunohistochemistry and morphometric approaches to identify 
and quantify the morphological changes. Quantitative reverse transcriptase 
PCR was applied to provide additional mechanistic data on remodeling 
processes. In HCM, the left and right ventricular free wall and septal 
myocardium exhibited a significantly reduced overall cellularity, accompanied 
by a significant increase in interstitial Iba1-positive cells with macrophage 
morphology. In addition, the myocardium of almost half of the diseased hearts 
exhibited areas where cardiomyocytes were replaced by cell rich fibrous 
tissue with abundant small and medium sized vessels. HCM hearts also 
showed significantly higher transcription levels for several inflammatory and 
profibrotic mediators. Our results suggest that HCM is the consequence of 
cardiac remodeling processes that are the result of cardiomyocyte damage 
and to which macrophages contribute by maintaining an inflammatory and 
profibrotic environment.  
 
Keywords: cat, heart, hypertrophic cardiomyopathy, morphometry, 
myocardium, histopathology 
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Feline hypertrophic cardiomyopathy (HCM) is defined by an unexplained 
thickening of the left ventricular wall without dilation of the chambers and in 
absence of any other cardiac or non-cardiac disease that itself is capable of 
causing hypertrophy of the heart.28,29,31 HCM is the most commonly 
diagnosed cardiac disease in cats.8,29,31 It is a heterogeneous disease, both in 
its clinical presentation and progression.1 A retrospective study has shown a 
familial predisposition in Persian, American Shorthair, Maine Coon and 
Ragdoll cats.8 In Maine Coon and Ragdolls, HCM has been linked to 
mutations in a sarcomeric gene.23,24 Epidemiological studies have shown a 
sex predisposition for male cats and a mean age of 6 years at the time of 
diagnosis.1,28,29 Affected cats can present with signs of congestive heart 
failure (CHF) and arterial thromboembolism (AT), or can suffer sudden death, 
though many never exhibit any clinical signs of cardiac disease and die of 
non-cardiac conditions.4,28,32 
To the authors’ knowledge, the first study on feline primary myocardial 
disease and CHF was published in 1970; this and subsequent papers 
reported a range of pathological features for HCM.2,3,12,17,20 Macroscopically, 
feline HCM is characterised by a concentric symmetrical (generalised) or 
asymmetrical (focal) thickening of the interventricular septum, left ventricle, 
and the papillary muscles, often with dilation of the left atrium.32 
Cardiomyocyte hypertrophy and disarray, a variable degree of interstitial 
fibrosis, interstitial inflammatory cell aggregates and dysplasia of vessel walls 
have been described most frequently as histological features of HCM.3,4,17,20 
In one study on familial HCM in domestic shorthair cats one end-stage case 
with multifocal areas of partly extensive myocardial fibrosis accompanied by a 
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mononuclear cell infiltration was reported; the changes were interpreted as 
myocardial infarcts.4 Recent studies using a quantitative approach partially 
confirmed a diffuse or multifocal increase in interstitial fibrosis, but questioned 
cardiomyocyte hypertrophy and myofiber disarray as consistent features of 
HCM; they did neither find evidence of fiber branching nor significant 
differences in diameter and length of cardiomyocytes.3,16,17 The inflammatory 
component in HCM has so far been characterized based on the cell 
morphology (hematoxylin-eosin stain) and limited cytochemical stains (Leder 
stain for neutrophils) and appears to comprise lymphocytes, plasma cells, 
neutrophils, and macrophages.4,17 An ultrastructural study of the myocardium 
of cats with HCM identified degenerative changes, including mitochondrial 
damage, of cardiomyocytes and abundant extracellular matrix (ECM) 
deposition in the interstitium.6  
The aim of the present study was to systematically assess the morphological 
changes and underlying mechanisms in feline HCM, to gain a better 
understanding of its complex pathophysiology. For this purpose, light 
microscopy was employed as a morphologic fact finding tool. This was 
followed by a quantitative, morphometric approach, which was complemented 
by a molecular investigation to assess the transcription of relevant markers 
and evaluate ongoing remodeling processes. 
 
Materials and Methods 
Animals and Tissue Sampling 
The study was conducted on hearts of 36 cats (Table 1), 18 cats with HCM 
(Table 1A), and 18 control cats (i.e. cats that had died or were euthanized 
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with diseases not involving the heart; Table 1B). All HCM cats underwent a 
full post mortem examination with owners’ consent. Two thirds (12/18) had 
been clinically confirmed and had undergone echocardiography carried out by 
a specialist in veterinary cardiology. The remaining six cases had been 
submitted for necropsy due to sudden death and clinical suspicion of cardiac 
disease. These cats showed marked left ventricular hypertrophy and left atrial 
dilation consistent with previously reported gross features of HCM,12 in the 
absence of gross and histological changes suggestive of systemic disease. 
The majority of the control animals (12/18) had also undergone a full post 
mortem examination, the remaining third (6/18) were only available for a 
partial necropsy, and the diagnosis relied on the clinical examination and the 
gross assessment of the heart by the cardiologist. Samples for histology were 
collected from the right ventricular free wall (RV), left ventricular free wall (LV) 
and interventricular septum (IVS) and fixed in 10% neutral-buffered formalin. 
From 11 HCM and 10 control animals (of these, hearts had been removed 
within 1 h after death; Table 1), samples from each cardiac location were 
placed in RNAlater (Ambion, Life Technologies, Paisley, UK) and frozen at -
80°C for subsequent RNA extraction.10 From two animals (case nos. 1.8, 1.9; 
Table 1), additional myocardial samples were fixed in 5% glutaraldehyde, 
buffered in 0.2 M cacodylic acid buffer, pH 7.3, for transmission electron 
microscopy. 
 
Histology, Immunohistochemistry and Fluorescence Examinations  
After formalin fixation, myocardial samples were trimmed and routinely 
paraffin wax embedded. Consecutive sections (3 - 5 µm) were prepared and 
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routinely stained with hematoxylin-eosin (HE) and the van Gieson stain for the 
demonstration of collagen deposition, or were subjected to 
immunohistochemiical and fluorescence staining. Immunohistochemistry was 
performed using a Dako autostainer (Dako, Glostrup, Denmark) or the 
Discovery XT autostainer (Ventana Medical System, Inc., Tucson, USA) and 
was applied to detect leukocytes (CD18+, MHC II+) and, specifically, T cells 
(CD3+), B cells (CD20+), macrophages (Iba-1+) and recently blood derived 
macrophages (calprotectin+), blood vessels, i.e. vascular endothelial cells 
(Factor VIII-related antigen (Factor VIII)+) and smooth muscle cells (α-smooth 
muscle actin (α-SMA)+). Antibodies and the respective antigen retrieval and 
detection methods are listed in Table 2. Briefly, after deparaffinization, antigen 
retrieval was performed for all antigens except for α-SMA, by incubation of the 
slides with citrate buffer (pH 6) at 98°C for 10 min or EDTA buffer (pH 9) at 
98°C for 20 min. Endogenous peroxidase was blocked by incubation with 
hydrogen peroxide solution for 10 min. Slides were incubated with equine 
serum for 30 min at room temperature followed by the primary antibodies and 
matching secondary antibodies; different detection kits were then applied 
(Table 2). Sections were washed with phosphate buffered saline between 
each incubation step (pH 8). Finally, sections were counterstained with 
hematoxylin for 40 s and mounted. A further section underwent fluorescence 
staining to mark cell nuclei, using the ProLong Diamond Antifade Mountant 
with DAPI (4', 6-diamidino-2-phenylindole; Invitrogen, Carlsbad, USA). Briefly, 
after deparaffinization and rehydration, sections were incubated with DAPI for 
24 h at room temperature in the dark. 
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Transmission Electron Microscopy (TEM)  
After glutaraldehyde fixation for 24 h, the myocardial specimens were trimmed 
and routinely embedded in epoxy resin. Toluidine blue-stained semithin 
sections (1.5 μm) were prepared to select areas of interest for the preparation 
of ultrathin sections (75 nm) that were contrasted with lead citrate and uranyl 
acetate and viewed with a Philips CM10, operating with a Gatan Orius 
Sc1000 digital camera (Gatan Microscopical Suite, Digital Micrograph).  
 
Morphometric Analyses 
A morphometric approach was taken to quantify the overall cellularity of the 
myocardium, the interstitial cellularity as well as the amount of interstitial 
collagen and the interstitial space in HCM in comparison to the myocardium of 
control cats. 
Slides stained for Iba-1 and α-SMA, with the van Gieson stain, and for DAPI 
fluorescence were scanned using a digital slide scanner (NanoZoomer-XR 
C12000; Hamamatsu, Hamamatsu City, Japan) and evaluated with the 
computer program VIS (Visiopharm Integrator System, Version 5.0.4. 1382; 
Visiopharm, Hoersholm, Denmark). For all quantitative approaches, 20 
regions of interest (ROIs) with a size of 2.37 mm2 (the area of a high power 
field with one ocular of 22 mm field of view) were randomly selected in the LV 
and RV and the IVS of all hearts. The van Gieson stain served to assess the 
proportion of space occupied by collagen, the proportion of interstitial empty 
space (i.e. cell- and fiber-free space) and the proportion of space occupied by 
cardiomyocytes (i.e. contractile tissue), each as % area. A threshold 
classification allowed recognition of fibrous tissue (bright pink), 
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cardiomyocytes (yellow) and interstitial empty space (empty) in each ROI, and 
the results were expressed as % of assessed tissue per ROI.  
Sections stained for Iba-1 were used to quantify the amount of macrophages 
in the interstitium. A threshold classification allowed recognition of positive 
(intense brown staining of the entire cytoplasm) and negative cells in each 
ROI, and the results were expressed as absolute number of positive nuclei 
per ROI. In a post-processing step, very small nuclei (nuclear area < 5 μm2) 
were excluded from counting in order to avoid that areas of increased 
background staining were falsely classified as nuclei. Nuclei that occurred in 
groups were often mistakenly classified as only one nucleus by the program 
and were therefore excluded from automated counting (nuclear area > 120 
μm2). Sections stained for α-SMA were used to determine the amount of 
small- to medium-sized vessels (identified as α-SMA positive vascular rings). 
Sections stained with DAPI fluorescence served to assess the amount of 
nuclei and thereby the overall cellularity of the myocardium. The intensity of 
the DAPI channel in NDP.view was set to be at 150% with a γ-value of 1.5 for 
all scans. A median unsharp filter (x = 55, y = 55) to remove background 
variation was added to the blue color channel (RGB-B) as a pre-processing 
step. With this method, the nuclei of all cell types were counted 
(cardiomyocytes, interstitial cells, vascular endothelial cells and smooth 
muscle cells).  
 
Quantitative Reverse Transcriptase PCR (qRT-PCR) for Relevant 
Remodeling Mediators 
For the amplification of the cytokines interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-
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18, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-ß, 
interferon (IFN)-γ, the matrix metalloproteinases (MMP)-2, -3, -13 and the 
tissue inhibitors of matrix metalloproteinases (TIMP)-1, -2, -3 published primer 
pairs and protocols were applied.10 
 
Statistical Analysis  
Data from morphometric measurements and qRT-PCRs were entered into 
spreadsheets and statistical analysis was performed using a commercially 
available software package (IBM SPSS Statistics 21, Portsmouth, UK). Basic 
descriptive statistics (mean, median, variance, standard deviation, 
interquartile range and confidence interval) were calculated for the variables 
recorded. Distribution of data was analysed applying graphical Q-Q plots, 
Kolmogorov Smirnov and Shapiro-Wilk analyses. Data from morphometric 
measurements and qRT-PCR results were not normally distributed and log 
transformed to improve normality and the model assumptions necessary for 
parametric analysis. Results between groups and regions were compared 
using 1-way ANOVA and Tukeys post hoc and unpaired t-tests. Scatter plots 
and linear regression analysis was used to investigate the relationship 
between data from morphometric measurements and age. Results are 
displayed as mean and standard deviation. Statistical significance was 
defined as p < 0.05. 
 
Results  
Study population 
The group of 18 HCM cats (Table 1A) comprised one female, two male and 
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15 male neutered cats with a mean age of 7.6 years (±3.06 years) and a 
mean body weight of 5.6 kg (±1.8 kg). Three cats (1.7, 1.10, 1.11), all male 
neutered exhibited a left AT; with a mean age of 10 years (±2.6 years), they 
were older than the remaining 15 HCM cats without AT (mean age: 7.1 years 
(±2.9 years)).  
The group of 18 control cats (Table 1B) comprised one female, 11 female 
neutered, two male and four male neutered cats. Their mean age of 7.7 years 
(±4.8 y) was similar to that of the HCM group. The mean body weight was 3.9 
kg (±1.1 kg) and thereby significantly lower than the mean body weight of the 
HCM cats (p=0.001).  
Of the 11 HCM cats examined by qRT-PCR, 10 were male neutered and one 
was male intact. The cats had a mean age of 8.5 years (±3.2 y) and a mean 
body weight of 5.3 kg (±1.8 kg). The ten control cats examined by qRT-PCR 
were female neutered animals, except one male and one male neutered. 
Their mean age was 10 years (±5.1 years), which was similar to that of the 
HCM cats (p=0.215).  
 
The composition of the feline myocardium is influenced by age.  
The unaltered myocardium (RV, LV, IVS) of the control cats was 
morphometrically assessed for a range of parameters (cellularity, amount of 
interstitial vessels (α-SMA+) and macrophages (Iba-1+), proportion of area 
covered by cardiomyocytes (i.e. contractile tissue) and by the interstitium) to 
identify any regional and/or age-related variation (Table 3). This did not show 
regional differences (Table 3B), but a weak negative correlation of age with 
overall cellularity and proportion of contractile tissue, as well as a moderate 
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negative correlation of age with the amount of small vessels and 
macrophages in the interstitium (Table 3C). Interestingly, there was a weak 
negative correlation of age and the amount of interstitial collagen in HCM 
(Table 3C). 
 
HCM is associated with an increase in interstitial macrophages and small- to 
medium-sized vessels and a regional increase in interstitial collagen.  
All hearts were screened for histological features repeatedly described in 
HCM, i.e. cardiomyocyte disarray and degeneration, leukocyte infiltration and 
interstitial fibrosis.3,4,11,17,20 Some or all of the above listed features were 
observed in most HCM cases (15/18; 83%). There was patchy to 
disseminated mild multifocal loss and/or degeneration of cardiomyocytes, the 
latter represented by loss of striation and occasional intracytoplasmic 
microvacuolization (Fig. 1), and variably intense, slight to mild multifocal 
interstitial collagen deposition (Figs. 2, 3) together with the presence of 
spindloid cells (fibroblasts; Fig. 2) that were occasionally α-SMA positive 
(myofibroblasts).  
In addition, all HCM cases exhibited evidence of mild diffuse interstitial 
widening (Fig. 1), occasional interstitial accumulations of mature adipocytes 
(fatty infiltration) and an increased interstitial cellularity (Figs. 2, 3). The latter 
was mainly due to the presence of mononuclear cells with macrophage 
morphology, i.e. round to spindle-shaped cells with a moderate to high 
amount of cytoplasm and an oval to round nucleus (Fig. 2). The majority of 
these cells exhibited strong Iba-1 (Fig. 4a) and MHC II expression (Fig. 4b) 
but were calprotectin-negative (Fig. 4c), suggesting that they were resident or 
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formerly blood-derived macrophages which had proliferated locally, rather 
than recently blood derived macrophages.34 A few individual cells in the 
interstitium were identified as T cells (CD3+) and B cells (CD20+). Occasional 
small to medium-sized intramural vessels showed mild media hypertrophy, 
without significant narrowing of the lumen.  
The quantitative assessment confirmed a significant increase in interstitial Iba-
1- positive cells in HCM cats across all three assessed localisations, and an 
overall significant increase in interstitial small to medium sized vessels, which 
was due to a significant difference in IVS and LV. Alongside this, the amount 
of interstitial collagen was significantly higher in the IVS of HCM cats 
compared to controls. The results are detailed in Table 3A and B.  
 
In HCM, the myocardium frequently exhibits focal areas of cardiomyocyte 
replacement by cell rich fibrous tissue.   
In eight of the 18 HCM hearts (44%), the myocardium exhibited one or more 
poorly delineated areas where cardiomyocytes were replaced by a cell rich 
infiltrate (Fig. 5) with degenerate (shrinkage, loss of striation, 
hypereosinophilia, intracytoplasmic vacuolization) and rare necrotic 
cardiomyocytes in the periphery (Fig. 6). The core of these lesions was 
represented by densely-packed collagen bundles into which spindloid cells 
(fibroblasts) and mononuclear cells with a morphology similar to those found 
in increased numbers in the interstitium were embedded (Fig. 7). The latter 
cells were also Iba-1- (Fig. 8a) and MHC II-positive, but calprotectin-negative. 
Scattered T cells (CD3+) and B cells (CD20+) were also found. Between the 
Iba-1-positive cells were abundant small to medium-sized vessels, confirmed 
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by the ring-like structures formed and identified by Factor VIII-positive 
endothelial cells, as well as α-SMA-positive pericytes and vascular wall 
associated smooth muscle cells (Fig. 8b). A few individual spindle-shaped 
cells were also found to express α-SMA (myofibroblasts) (Fig. 8b). The 
degeneration of individual cardiomyocytes in the periphery of the focal lesions 
was confirmed by TEM (Fig. 9). Individual or multiple cardiomyocytes were 
found embedded and walled off by dense and partially irregularly arranged 
collagen fiber bundles (Fig. 9b, 9c), and showed myofiber disarray and 
disruption of intercalated discs with marked disorganization and interdigitation 
of Z-lines (Fig. 9d). 
 
The pathological changes in the myocardium with HCM are associated with 
significant upregulation of pro-inflammatory and pro-fibrotic mediators. 
Quantitative RT-PCR results confirmed the constitutive expression of 
cytokines, MMPs and TIMPs in the myocardium of all cats.10 However, cats 
with HCM showed significantly higher transcription levels for IL-1, IL-6, IL-18, 
TNF-a, TGF-β, MMP-13, and TIMP-1 (Table 4A). As previously reported, 
control cats exhibited a moderate positive correlation of age and myocardial 
TGF-β transcription and a moderate negative correlation of IL-4 mRNA levels 
and age.10 For HCM cats a strong negative correlation with age was observed 
for IL-8, MMP-2 and MMP-13, a moderate negative correlation for IFN-g, TGF-
β, MMP-3 and TIMP-2, and a weak negative correlation for IL-2 and IL-4 
(Table 4B). 
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Discussion  
Feline HCM is a disease with a complex pathophysiology that is yet far from 
clear. Several studies have been carried out in recent years to characterize 
and quantify its morphological features, reporting fibrosis, myofiber disarray or 
hypertrophy, and inflammatory components.3,4,16,17,20 Their results are, at least 
in part, controversial which left open many questions on the pathogenesis of 
this relevant entity.29  
We have recently shown that the normal myocardium of cats is actively 
transcribing a range of inflammatory and remodeling mediators, with a clear 
age- and sex-related variation and a shift from a pro-inflammatory state in 
young age to a pro-fibrotic state with increasing age; the former being more 
pronounced in male cats.10 Considering also that HCM is a disease 
particularly of older, intact or neutered male cats,1,25,29 we aimed to further 
investigate the pathological features of the myocardium in HCM, with 
particular emphasis on the associated remodeling processes.  
Grossly, all HCM hearts exhibited the typical diffuse thickening of the LV 
and/or the IVS and a dilation of the left atrium.12 Histology confirmed the 
presence of several previously described features, i.e. cardiomyocyte disarray 
and degeneration and interstitial fibrosis, as well as leukocyte infiltration, in 
most cases.2–4,17,20 Other studies described marked media hypertrophy, 
fibrosis and elastosis of intramural vessels in feline HCM.12,20 These features 
were not prominent in our HCM cohort where the vascular changes were 
restricted to mild media hypertrophy in small to medium-sized intramural 
vessels. However, the present study identified several additional, rather 
subtle, but consistent and statistically significant quantitative changes: an 
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overall increase in the amount of interstitial Iba-1-positive mononuclear cells, 
small and medium sized vessels, and collagen. The difference was most 
reliably demonstrated in the IVS, followed by the LV, whereas in the RV, the 
quantitative changes were restricted to the increased amount of interstitial 
Iba-1-positive cells. Interestingly, the increase in interstitial cells was not 
associated with an increase in overall cell numbers, suggesting a reduction of 
cardiomyocytes, which is indirect evidence of some degree of diffuse 
cardiomyocyte injury and loss. Immunohistochemistry confirmed the 
mononuclear interstitial cells as macrophages, as these were in the vast 
majority not only Iba-1-, but also MHC II-positive. The lack of calprotectin 
expression suggests that they were resident or locally proliferated 
macrophages, rather than recently recruited from the blood into the 
myocardium.34 T cells and B cells were not more numerous in HCM than in 
the control myocardium. 
The focal lesions, which were found in addition to the diffuse changes in a 
large proportion of HCM hearts, were most prominent in IVS and LV, i.e. the 
regions that show the characteristic thickening and were found to exhibit the 
most severe diffuse changes. These focal infiltrates, with their core of fibrous 
tissue and abundant embedded macrophages and new vessels, are 
reminiscent of infarct-like lesions and disorderly arranged granulation 
tissue.4,7,13 The presence of dying cardiomyocytes in the periphery, where 
they seem to be walled off by collagen fibers, suggests that these infiltrates 
are actively expanding. Their random distribution indicates that they are 
initiated by focal tissue damage, i.e. cardiomyocyte death.  
The findings suggest that HCM is not of a classical inflammatory nature with 
 
2 
		
 21	
persistent recruitment and interaction of inflammatory cells in the myocardium. 
Instead, also in light of the significant increase in interstitial small vessels and 
the diffuse interstitial collagen deposition, a diffuse macrophage-driven 
remodeling process is suspected. The interstitial macrophages could 
represent a primary inflammatory component, and their recruitment and 
proliferation could be initiated by the myocardium itself. Cardiomyocytes are a 
known source of cytokines, constitutively transcribing a panel of inflammatory 
and profibrotic mediators, e.g. IL-1, Il-6, TNF-a, INF-g and TGF-b.10 Their 
expression can be enhanced by cardiomyocyte injury.27 Activated 
macrophages could then be responsible for the formation of new interstitial 
vessels, the proliferation respectively activation of fibroblasts and the 
occurrence of myofibroblasts as well as the deposition of interstitial collagen, 
through the release of angiogenic and fibrogenic mediators. Indeed, we found 
a significant increase in the transcription of inflammatory (IL-1, IL-6, IL-18, 
TNF-a) and profibrotic (TGF-β, MMP-13, and TIMP-1) mediators in HCM. 
Involvement of inflammatory cytokines in myocardial remodeling in feline 
HCM is therefore likely, and both the cardiomyocytes and abundant 
macrophages might be the sources.10,14,33  
Together, new vessel formation, fibroblast proliferation and collagen 
deposition in the focal lesions represent key events in granulation tissue 
formation.19 Angiogenesis in general represents a fundamental component of 
repair processes and is critical for the maintenance of the required blood flow 
at sites of injury or ischemia.46 Fibroblasts then migrate into the damaged 
tissue and produce collagen-rich connective tissue to maintain the structural 
integrity.19,36 
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In HCM, the diffuse increase in interstitial vessels is likely also due to new 
vessel formation, which is known to be triggered by hypoxia.18 Low oxygen 
levels lead to up-regulation of various pro-angiogenic pathways promoting 
increased vessel sprouting.18 In humans it has been shown that compared to 
their normoxic counterparts, cardiomyocytes exposed to constant hypoxia 
have elevated secretion levels of inflammatory cytokines, including IL-1, IL-6, 
IL-8, as well as certain growth factors and chemokines.15  
The initial cause of myocardial damage in feline HCM that would trigger the 
observed remodeling processes is still unknown, but hypoxia appears likely 
considering the present findings.4,12 So far unknown structural or functional 
myocardial alterations could result in latent myocardial hypoxia, leading to 
individual cardiomyocyte degeneration and death. Focally pronounced or 
chronic hypoxia could then result in a larger area of cardiomyocyte necrosis, 
leading to the observed focal lesions. Here, the release of chemokines and 
cytokines and dead cardiomyocytes can induce recruitment and proliferation 
of macrophages which subsequently clear the cellular debris and secrete 
those chemokines and cytokines that are responsible for all other 
processes.5,30 This hypothesis is supported by the observed increase in 
vessels in our case cohort and by the fact that a hypoxic environment can 
induce a macrophage driven inflammatory response, where recruited, blood-
derived monocytes differentiate into macrophages that reside in areas of 
hypoxic damage.26  
In human HCM patients, myocardial ischemia is the result of changes in the 
coronary arteriolar microvasculature.21,22,35 In our feline cohort, there is no 
evidence of a similar scenario in cats.12  
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We have previously shown that the myocardium of young, male cats is in a 
pronounced pro-inflammatory and potentially alerted state.10 This might 
provide a favourable environment for cardiomyocyte damage, if appropriately 
triggered. Alternatively, susceptible cats might exhibit persistent endogenous 
upregulation of cytokines, which would render cardiomyocytes more prone to 
injury even after mild hypoxic events.  
Also, with age the hearts of humans undergo various functional and 
morphological changes, including a thickening of the LV, gradual decline of 
the number of cardiomyocytes accompanied by an increase of collagen, 
fibrotic changes in the valves, and vascular remodeling with progressive 
intimal thickening.9 We have not observed similarly striking processes in the 
myocardium of old cats without cardiac disease, but have previously shown 
that the myocardial mediator transcription pattern shifts from a pro-
inflammatory state in young animals to a pro-fibrotic state in age.10  The 
morphometric analysis of the present study now adds data on age-related 
changes in the composition of the myocardium: with age, the cellularity, the 
amount of interstitial blood vessels and macrophages, and the proportion of 
contractile tissue decreases, suggesting a decreased reactivity and with it, 
possibly, repair of the myocardium of older cats. Such impaired cardiac repair, 
alongside continuous, slow disease progression could lead to the observed 
and more pronounced damage with reduced tissue and immune reaction in 
older animals. This might also promote AT formation, as the cats with AT in 
our HCM cohort were older than those without AT. 
In conclusion, the results of our study provide further evidence that the 
increase in wall thickness and relative cardiac weight in feline HCM is not the 
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result of true myocardial hypertrophy, but due to a diffuse expansion of the 
interstitium by vessels, macrophages and collagen as a consequence of 
degeneration and repair processes triggered by a still unknown cause. In 
HCM, the hearts seem to exhibit a long-term, progressive myocardial 
remodeling process. On a cellular level this process is likely driven by 
cardiomyocytes and local macrophages. Further studies are required to 
identify the type and source of these macrophages and further specify their 
role in the pathogenetic process of feline HCM. 
 
Acknowledgements  
We thank the technical staff of the Histology Laboratory and the TEM Unit, 
Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, as 
well as the staff of the Histology Laboratory, Faculty of Veterinary Medicine, 
University of Helsinki, for excellent technical assistance.  
 
 
 
 
 
 
 
 
 
 
 
2 
		
 25	
References  
1.  Abbott JA. Feline hypertrophic cardiomyopathy: An update. Vet Clin 
North Am - Small Anim Pract. 2010;40(4):685–700.  
2.  Aupperle H, Baldauf K, März I. An immunohistochemical study of feline 
myocardial fibrosis. J Comp Pathol. 2011;145(2-3):158–173.  
3.  Biasato I, Francescone L, La Rosa G, Tursi M. Anatomopathological 
staging of feline hypertrophic cardiomyopathy through quantitative 
evaluation based on morphometric and histopathological data. Res Vet 
Sci. 2015;102:136–141.  
4.  Cesta MF, Baty CJ, Keene BW, Smoak IW, Malarkey DE. Pathology of 
end-stage remodeling in a family of cats with hypertrophic 
cardiomyopathy. Vet Pathol. 2005;42(4):458–467.  
5.  Chen B, Frangogiannis NG. Macrophages in the remodeling failing 
heart. Circ Res. 2016;119(7):776–778.  
6.  Christiansen LB, Prats C, Hyttel P, Koch J. Ultrastructural myocardial 
changes in seven cats with spontaneous hypertrophic cardiomyopathy. 
J Vet Cardiol. 2015;17:220–232.  
7.  Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG. The 
extracellular matrix as a modulator of the inflammatory and reparative 
response following myocardial infarction. J Mol Cell Cardiol. 
2010;48(3):504–511.  
8.  Ferasin L, Sturgess CP, Cannon MJ, Caney SMA, Gruffydd-Jones TJ, 
Wotton PR. Feline idiopathic cardiomyopathy: a retrospective study of 
106 cats (1994-2001). J Feline Med Surg. 2003;5(3):151–159.  
 
2 
		
 26	
9.  Fleg JL, Strait J. Age-associated changes in cardiovascular structure 
and function: a fertile milieu for future disease. Heart Fail Rev. 
2012;17:545–554.  
10.  Fonfara S, Hetzel U, Hahn S, Kipar A. Age- and gender-dependent 
myocardial transcription patterns of cytokines and extracellular matrix 
remodelling enzymes in cats with non-cardiac diseases. Exp Gerontol. 
2015;72:117–123.  
11.  Fox PR, Maron BJ, Basso C, Liu SK, Thiene G. Spontaneously 
occurring arrhythmogenic right ventricular cardiomyopathy in the 
domestic cat: A new animal model similar to the human disease. 
Circulation. 2000;102:1863–1870.  
12.  Fox PR. Hypertrophic cardiomyopathy. Clinical and pathologic 
correlates. J Vet Cardiol. 2003;5(2):39–45.  
13.  Frangogiannis NG. Regulation of the inflammatory response in cardiac 
repair. Circ Res. 2012;110(1):159–173.  
14.  Frangogiannis NG. The inflammatory response in myocardial injury, 
repair, and remodelling. Nat Rev Cardiol. 2014;11:255-262.  
15.  Hafner C, Wu J, Tiboldi A, et al. Hyperoxia induces inflammation and 
cytotoxicity in human adult cardiac myocytes. Shock. 2017;47(4):436–
444.  
16.  Kershaw O, Heblinski N, Lotz F, Dirsch O, Gruber AD. Diagnostic value 
of morphometry in feline hypertrophic cardiomyopathy. J Comp Pathol. 
2012;147(1):73–83.  
17.  Khor KH, Campbell FE, Owen H, Shiels IA, Mills PC. Myocardial 
 
2 
		
 27	
collagen deposition and inflammatory cell infiltration in cats with pre-
clinical hypertrophic cardiomyopathy. Vet J. 2015;203(2):161–168.  
18.  Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and 
evil. Genes Cancer. 2011;2(12):1117–1133.  
19.  Kumar V, Stanley L, Cotran RS. Inflammation and repair: tissue repair. 
In: Kumar V, Abbas AK, Aster JC, Robbins SL, ed. Robbins and Cotran 
Pathologic Basis of Disease. Philadelphia: Elsevier; 2015:100–111.  
20.  Liu SK, Maron BJ, Tilley LP. Feline hypertrophic cardiomyopathy: gross 
anatomic and quantitative histologic features. Am J Pathol. 
1981;102(3):388–395.  
21.  Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (“small 
vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am 
Coll Cardiol. 1986;8(3):545–557.  
22.  Maron BJ. Hypertrophic cardiomyopathy. JAMA. 2002 Mar 
13;287(10):1308–1320.  
23.  Meurs KM, Norgard MM, Ederer MM, Hendrix KP, Kittleson MD. A 
substitution mutation in the myosin binding protein C gene in ragdoll 
hypertrophic cardiomyopathy. Genomics. 2007;90:261–264.  
24.  Meurs KM, Sanchez X, David RM, et al. A cardiac myosin binding 
protein C mutation in the Maine Coon cat with familial hypertrophic 
cardiomyopathy. Hum Mol Genet. 2005;14(2):3587–3593.  
25.  Migliorini F. Miocardiopatie feline. Man di Cardiol del Cane e del Gatto, 
Prima Ed. 2012;205–224.  
26.  Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the 
 
2 
		
 28	
recruitment of macrophages into hypoxic areas of tumors and other 
ischemic tissues. Blood. 2004;104(8):2224-2234.  
27.  Noji Y, Shimizu M, Ino H, et al. Increased circulating matrix 
metalloproteinase-2 in patients with hypertrophic cardiomyopathy with 
systolic dysfunction. Circ J. 2004;68(4):355–360.  
28.  Payne JR, Borgeat K, Brodbelt DC, Connolly DJ, Luis Fuentes V. Risk 
factors associated with sudden death vs. congestive heart failure or 
arterial thromboembolism in cats with hypertrophic cardiomyopathy. J 
Vet Cardiol. 2015;17:318–328.  
29.  Payne JR, Brodbelt DC, Luis Fuentes V. Cardiomyopathy prevalence in 
780 apparently healthy cats in rehoming centres (the CatScan study). J 
Vet Cardiol. 2015;17:244–257.  
30.  Raggi F, Blengio F, Eva A, Pende D, Varesio L, Bosco MC. 
Identification of CD300a as a new hypoxia-inducible gene and a 
regulator of CCL20 and VEGF production by human monocytes and 
macrophages. Innate Immun. 2013;20(7):721–734.  
31.  Riesen SC, Kovacevic A, Lombard CW, Amberger C. Prevalence of 
heart disease in symptomatic cats: An overview from 1998 to 2005. 
Schweiz Arch Tierheilkd. 2007;149(2):65–71.  
32.  Robinson WN, Robinson NA. Myocardial disease: cardiomyopathies. In: 
Maxie MG, ed. Jubb, Kennedy & Palmer’s Pathology of Domestic 
Animals. St.Louis, Missouri; 2016:44–50.  
33.  Soehnlein O, Lindbom L. Phagocyte partnership during the onset and 
resolution of inflammation. Nat Rev Immunol. 2010;10:427.  
 
2 
		
 29	
34.  Susta L, Torres-Velez F, Zhang J, Brown C. An in situ hybridization and 
immunohistochemical study of cytauxzoonosis in domestic cats. Vet 
Pathol. 2009;46(6):1197–1204.  
35.  Waller BF, Maron BJ, Epstein SE, Roberts WC. Transmural myocardial 
infarction in hypertrophic cardiomyopathy. Chest. 2018;79(4):461–465.  
36.  Weber KT, Anversa P, Armstrong PW, et al. Remodeling and reparation 
of the cardiovascular system. J Am Coll Cardiol. 1992;20(1):3–16.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
		
 30	
 
Table 1. Animals included into the study. In all cases, a histological and 
immunohistological examination including a morphometric analysis were 
undertaken. 
A. Cats diagnosed with hypertrophic cardiomyopathy (HCM). 
Case No Breed Age (years) Sex 
1.1a DSH 10 M 
1.2a DLH 8 MN 
1.3a DSH 3 MN 
1.4a DSH 8 MN 
1.5a DSH 7 MN 
1.6a BSH 8 MN 
1.7a DLH 12 MN 
1.8a,b Ragdoll 3 MN 
1.9a,b DSH 9 MN 
1.10a DSH 14 MN 
1.11 a DLH 8 MN 
1.12 MC 6 MN 
1.13 DSH 3 M 
1.14 MC 4 MN 
1.15 Devon Rex 7 MN 
1.16 DSH 11 MN 
1.17 MC 1.5 F 
1.18 DSH 6 MN 
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B. Control animals. 
Case No Breed Age (years) Sex 
2.1a DSH 14 FN 
2.2a DSH 18 FN 
2.3a DSH 14 M 
2.4a DSH 10 FN 
2.5a DSH 2 FN 
2.6a DSH 15 FN 
2.7a DSH 3 FN 
2.8a DSH 9 FN 
2.9a DSH 10 FN 
2.10a DSH 5 MN 
2.11 DSH 6 MN 
2.12   DSH 5 MN 
2.13   DLH 5 FN 
2.14 DSH 2.5 FN 
2.15 DSH 4 M 
2.16 DSH 4 F 
2.17 DSH 2.5 FN 
2.18 DSH 9 MN 
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BSH, British Shorthair; DLH, Domestic Longhair; DSH, Domestic Shorthair; F, 
female; HCM, hypertrophic cardiomyopathy; M, male; MC, Maine Coon; N, 
neutered. 
a: qRT-PCR undertaken; b: TEM undertaken 
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Table 2. Antibodies and immunohistologicaI methods.  
Antigen Expression  Antibody 
(clone) 
Source Dilution Pretreat-
ment 
Detection 
method 
CD3 T cells Mouse mAb 
(F.7.2.38) 
Dako  1:200 EDTA EnVision Mouse 
CD20 B cells Rabbit pAb Thermo Scientific 1:1000 - EnVision Rabbit 
Factor VIII 
(-related Ag) 
Endothelial cells, megakaryo-
cytes, platelets, mast cells 
Rabbit pAb Dako 1:100 Citrate EnVision Rabbit 
MHC II  
(HLA-DR) 
Macrophages, B and T cells, 
dendritic cells 
Mouse mAb 
(TAL 1B5) 
Abcam 1:1500 
 
Citrate EnVision Mouse 
Iba-1 Microglia, macrophages  Rabbit pAb Wako 1:750 Citrate EnVision Mouse 
α-SMA 
 
Smooth muscle cells, myo-
fibroblasts, myoepithelial cells 
Mouse mAb 
(1A4) 
Dako 1:400 - Dako REAL 
 
Ag, antigen; α-SMA, α-smooth muscle actin; CD, cluster of differentiation; 
Citrate, citrate buffer pretreatment; EDTA, EDTA pretreatment; HLA-DR, 
human leukocyte antigen – antigen D related; HRP, horseradish peroxidase; 
Iba-1, ionized calcium binding adaptor molecule 1; mAb, monoclonal antibody; 
MHC, major histocompatibility complex; n/d, not done; pAb, polyclonal 
antibody.  
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Table 3. Comparison of overall cellularity, number of interstitial small vessels and 
macrophages (i.e. Iba-1+ cells), and percentage of area covered by cardiomyocytes, 
collagen and fiber- and cell-free interstitial space as well as the ratio of contractile 
and non-contractile tissue in the myocardium (right and left ventricle, interventricular 
septum) of 18 control cats and 18 cats with HCM.  
 
A. Overall assessment, based on the available data for all three cardiac regions 
(mean ± standard deviation). 
 Control HCM P-value 
DAPI 3.1 (± 0.8) 3.0 (± 0.9) 0.066 
SMA 2.2 (±0.4) 2.4 (±0.3) 0.001 
Iba-1 0.9 (±0.4) 1.6 (±0.4) <0.001 
Cardiomyocytes 1.9 (±0.05) 1.9 (±0.1) 0.18 
Collagen 0.62 (±0.3) 0.74 (±0.2) 0.039 
Interstitial space 1.25 (±0.2) 1.3 (±0.3) 0.23 
Contractile vs non-contractile 
tissue ratio 
0.78 (±0.3) 0.71 (±0.3) 0.27 
 
DAPI: number of cells per 20 ROI, based on the number of DAPI positive fluorescent 
nuclei; SMA: number of a-SMA positive small to medium sized vessels per 20 ROI; 
Iba-1: number of Iba-1 positive interstitial cells per 20 ROI; cardiomyocytes: 
percentage area per 20 ROI covered by cardiomyocytes (i.e. contractile tissue); 
collagen: percentage area per 20 ROI covered by collagen; interstitial space: 
percentage area per 20 ROI of fiber- and cell-free interstitial space 
 
DAPI, 4', 6-diamidino-2-phenylindole; Iba-1, ionized calcium-binding adapter 
molecule 1; SMA, α-smooth muscle actin.  
		
 35	
B. Comparison of the different cardiac regions (median, interquartile range).  
When the numbers of samples analysed differed from sample numbers provided for each region, the analysed numbers of samples are 
provided accordingly in the table. Results that are significantly different within rows are indicated by superscript symbols. 
 Control HCM 
 RV 
(n=18) 
IVS 
(n=18) 
LV 
(n=18) 
RV 
(n=12) 
IVS 
(n=14) 
LV 
(n=13) 
DAPI 3.0 (± 0.1) 
n=14 
3.1 (± 0.1) 
n=14 
3.1 (± 0.1) 
n=14 
3.0 (± 0.1) 
 
3.0 (± 0.1) 
n=12 
3.0 (± 0.1) 
n=14 
SMA 2.2 (± 0.4) 
 
2.2 (± 0.4)@ 
 
2.2 (± 0.5)$ 
 
2.3 (± 0.3) 
n=14 
2.5 (± 0.2)@ 
n=15 
2.5 (± 0.3)$ 
n=17 
Iba-1 0.9 (± 0.5)* 
 
1.0 (± 0.4)& 
 
1.0 (± 0.4)^ 
 
1.4 (± 0.4)* 
n=15 
1.6 (± 0.5)& 
n=16 
1.7 (± 0.4)^ 
n=16 
Cardiomyocytes  1.9 (± 0.06) 1.9 (± 0.05) 1.9 (± 0.05) 1.9 (± 0.1) 1.9 (± 0.1) 1.9 (± 0.1) 
Interstitial space 1.2 (± 0.3) 1.1 (± 0.3) 1.1 (± 0.3) 1.25 (± 0.3) 1.2 (± 0.3) 1.1 (± 0.4) 
Collagen 0.7 (± 0.3) 0.5 (± 0.3)# 0.6 (± 0.3) 0.6 (± 0.2) 0.8 (± 0.2)# 0.8 (± 0.2) 
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Contractile vs non-
contractile tissue 
ratio 
0.7 (± 0.3) 0.9 (± 0.3) 0.8 (± 0.2) 0.7 (± 0.3) 0.7 (± 0.3) 0.7 (± 0.3) 
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C. Correlation of the different parameters with age in age-matched control cats (n=18) and cats with HCM 
(n=18), based on the available data for all three cardiac regions. 
  Control HCM 
DAPI 
 
R-value 0.368  0.276 
Significance 0.017 ↓ 0.094 
SMA 
R-value 0.455 0.228 
Significance 0.001 ↓ 0.128 
Iba-1 
R-value 0.511 0.065 
Significance <0.001 ↓ 0.666 
Cardiomyocytes 
R-value 0.278 0.095 
Significance 0.042 ↓ 0.565 
Collagen 
R-value 0.007 0.354 
Significance 0.962 0.027 ↓ 
Interstitial space 
R-value 0.241 0.108 
Significance 0.08 0.513 
Contractile vs non-
contractile tissue ratio 
R-value 0.215 0.212 
Significance 0.118 0.196 
  
↓ - indicates negative correlation, i.e. a decrease with age; ↑- indicates positive correlation, i.e. an Figure 
legends 
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Table 4. Cytokine and remodeling marker transcription in the myocardium of cats with and without 
hypertrophic cardiomyopathy.  
 
A. Relative mRNA expression of cytokines and remodeling markers in the myocardium (interventricular 
septum, left and right ventricle) of control cats (n=10) and cats with HCM (n=11). 
 
Marker Control HCM P-value 
IL-1 -0.036 (±0.63) 0.34 (± 0.31) ↑ 0.01 
IL-2 1.72 (±0.46) 1.52 (±0.62) 0.181 
IL-4 1.38 (±0.49) 1.29 (±0.64) 0.592 
IL-6 0.056 (±0.56) 0.74 (±1.1) ↑ 0.01 
IL-8 1.88 (±0.48) 1.39 (±0.80) 0.083 
IL-18 1.93 (±0.67) 2.75 (±0.75) ↑ <0.001 
TNF-a -0.63 (±0.73) 0.26 (±0.45) ↑ <0.001 
IFN-γ 2.11 (±0.34) 2.0 (±0.34) 0.455 
TGF-b 2.20 (±0.43) 2.52 (±0.64) ↑ 0.031 
MMP-2 2.64 (±0.62) 2.75 (±0.65) 0.536 
MMP-3 1.53 (±0.38) 1.46 (±0.78) 0.669 
MMP-13 0.48 (±0.42) 0.93 (±0.48) ↑ <0.001 
TIMP-1 -0.41 (±0.50) -0.079(±0.51) ↑ 0.039 
TIMP-2 4.01 (±0.25) 3.88 (±0.56) 0.244 
TIMP-3 3.51 (±0.51) 3.63 (±0.95) 0.526 
 
Results are reported as mean and standard deviation of the logarithmic value (2–ΔΔCt) after normalization 
of the Ct value of the respective marker to the Ct value of GAPDH (relative expression). P-values 
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indicating significant differences are in bold. 
 
B. Correlation of cytokine and remodeling marker mRNA expression with age in control cats and cats with 
HCM, based on the available data for all three cardiac regions. 
  Control HCM 
IL-1 R-value 0.357 0.193 
Significance 0.068 0.389 
IL-2 
 
R-value 0.207 0.357 
Significance 0.300 0.049 ↓ 
IL-4 
 
R-value 0.393 0.321 
Significance 0.043 ↓ 0.019 ↓ 
IL-6 R-value 0.146 0.238 
Significance 0.478 0.263 
IL-8 
 
R-value 0.041 0.617 
Significance 0.910 0.001 ↓ 
IL-18 R-value 0.075 0.197 
Significance 0.709 0.287 
TNF-a 
 
R-value 0.238 0.224 
Significance 0.233 0.316 
IFN-γ R-value 0.187 0.435 
Significance 0.404 0.014 ↓ 
TGF-b R-value 0.432 0.526 
Significance 0.028 ↑ 0.002 ↓ 
MMP-2 R-value 0.285 0.740 
Significance 0.150 <0.001 ↓ 
MMP-3 R-value 0.159 0.357 
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Significance 0.429 0.049 ↓ 
MMP-13 
R-value 0.126 0.689 
Significance 0.531 <0.001 ↓ 
TIMP-1 
R-value 0.103 0.017 
Significance 0.667 0.942 
TIMP-2 
R-value 0.068 0.590 
Significance 0.756 <0.001 ↓ 
TIMP-3 
R-value 0.160 0.278 
Significance 0.425 0.129 
↓ - indicates negative correlation, i.e. a decrease with age; ↑- indicates positive correlation, i.e. an increase 
with age.  
 
HCM, hypertrophic cardiomyopathy; IL, interleukin; IFN-γ, interferon-γ; MMP, matrix metalloproteinase; 
TGF-b, transforming growth factor-b; TIMP, tissue inhibitor of metalloproteinases; TNF-a, tumor necrosis 
factor-a. 
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Figures 1-4. Hypertrophic cardiomyopathy (HCM), heart, cat, case no 1.8. Diffuse myocardial 
changes. Figure 1. There are individual degenerating cardiomyocytes that exhibit loss of striation 
and cytoplasmic microvacuolization (arrows); the interstitium appears widened (asterisk). HE 
stain. Figure 2. Mild interstitial collagen deposition (arrowhead) with presence of several 
fibroblasts and other mononuclear cells. Arrows: degenerating cardiomyocytes with loss of 
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striation. HE stain. Figure 3. Overview to highlight the widespread nature of interstitial collagen 
deposition and the increased interstitial cellularity. Insets: higher magnification. (a) HE stain, (b) 
van Gieson stain. Figure 4. A high proportion of the interstitial mononuclear cells exhibit Iba-1 (a) 
and MHC II (b) expression, but are calprotectin-negative (c). Arrowhead: calprotectin-positive 
monocyte within interstitial vessel. Immunohistochemistry, hematoxylin counterstain.  
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Figures 5-8. Hypertrophic cardiomyopathy (HCM), heart, cat, case no 1.9. Focal lesions. Figure 
5. Cardiomyocytes are replaced by a poorly delineated cell rich infiltrate. HE stain. Figure 6. 
Periphery of a focal lesion, with individual cardiomyocytes (arrows) that exhibit degenerative 
changes, such as shrinkage, loss of striation and hypereosinophilia. HE stain. Figure 7. The core 
of these lesions is comprised of densely-packed collagen bundles into which spindloid cells 
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(fibroblasts) and mononuclear cells with a macrophage morphology are embedded. Small vessels 
are also seen. (a) HE stain, (b) van Gieson stain. Figure 8. (a) A large proportion of the cells in 
the lesion are Iba-1-positive (inset: higher magnification to illustrate the morphology of the Iba-1-
positive cells). (b) In addition, there are numerous small to medium-sized vessels, confirmed by 
ring-like structures of α-SMA-positive pericytes and smooth muscle cells that comprise the media 
(inset). There are also individual α-SMA-positive spindloid, fiboblast-like cells consistent with 
myofibroblasts (arrowheads). Immunohistochemistry, hematoxylin counterstain. 
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Figure 9. Hypertrophic cardiomyopathy (HCM), myocardium, cat, case no 1.9. Focal lesions. (a) 
Individual cardiomyocytes in the periphery, embedded into collagen fibers, display degenerative 
changes, i.e. shrinkage, loss of striation, hypereosinophilia, cytoplasmic vacuolization and 
fragmentation (arrows). HE stain. (b-d) Ultrastructural features. (b) Cardiomyocyte (CM) with 
cytoplasmic vacuolization and mitochondrial (m) swelling, surrounded by mature collagen fibers 
(asterisks). (c) Cardiomyocyte (CM) with thin, irregularly arranged myofibrils (arrows), embedded 
and walled off by dense and partially irregularly arranged mature collagen fiber bundles (asterisk). 
(d) Cardiomyocytes showing features of degeneration, such as myofiber disarray and disruption 
of intercalated disc with marked disorganisation and interdigitation of Z-lines (arrows). 
Transmission electron microscopy. 
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